EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis

Murat Pekmez iD, Şefika Beyza Mete iD, Yunus Aksüt iD, İrem Öğütcü iD, Fatma Nur Baştürk iD, Yusuf Can Gerçek iD, Aslıhan Şengelen iD

Medical Oncology · 25.03.2025 · 42 (5)

DOI: 10.1007/s12032-025-02697-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 25.03.2025. Verfasst von Murat Pekmez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Balabanağa, Şehzadebaşı RoadVezneciler-Fatih, 34134, Istanbul,…. Hauptthemen laut MEDLINE: Glioblastoma, Epithelial-Mesenchymal Transition, Cerulenin, Endoplasmic Reticulum Stress. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul Üniversitesi, Istanbul University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting cellular metabolism is becoming a critical approach for stopping cancer progression. Limited information is available regarding the effects of inhibiting the lipogenic enzyme fatty acid synthase (FASN) in glioblastoma (GB) cells (grade-IV-astrocytoma), which have high invasion and low response to standard treatments. Herein, we used cerulenin (CER) to inhibit FASN. CER treatments (3.6 μg/mL/48 h and 5.55 μg/mL/48 h indicate IC 20 and IC 50 values, respectively) led to a dose- and time-dependent decrease in the viability of the U-87MG human GB cells. A significant decrease was detected in the levels of fatty acids, including palmitic acid, determined by GS-MS analysis. FASN inhibition attenuated cell motility, 2D and 3D-clonogenic survival, and cell differentiation characteristics (related markers of epithelial-mesenchymal transition/EMT and stemness). Moreover, treatments caused mitochondrial membrane potential (MMP) collapse and increased intracellular reactive oxygen species (ROS) levels. Protein aggregates and ER stress in the cells also increased. Remarkably, despite increased Hsp70 and p-HSF1 levels against induced cellular stress, CER promoted markedly autophagy and apoptosis. The network pharmacology approach revealed that protein and lipid kinases are crucial targets in cell signaling, and PI3K, AKT, and NF-κB levels were confirmed by immunoblotting. The results demonstrated for the first time that inhibiting FA production and FASN function induces cell death through ROS generation and ER stress while simultaneously reducing the motility and aggressiveness of U-87MG human glioblastoma cells by attenuating EMT and stemness phenotypes. Therefore, blocking lipid metabolism using CER may be considered as a good candidate for GB therapeutic option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaEpithelial-Mesenchymal TransitionCeruleninEndoplasmic Reticulum StressBrain NeoplasmsFatty Acid Synthase, Type IHumansNF-kappa BProto-Oncogene Proteins c-aktOxidative StressPhosphatidylinositol 3-KinasesCell Line, TumorSignal TransductionNeoplastic Stem CellsCell MovementReactive Oxygen SpeciesDisease ProgressionPhenotype

Stichwörter der Autor:innen

Anti-cancer effectCellular stress responseCerulenin (CER)Fatty acid synthase (FASN) inhibitorGlioblastoma

Substanzen

NF-kappa BProto-Oncogene Proteins c-aktCeruleninPhosphatidylinositol 3-KinasesFASN protein, humanFatty Acid Synthase, Type IReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Balabanağa, Şehzadebaşı RoadVezneciler-Fatih, 34134, Istanbul, Türkiye. mpekmez@istanbul.edu.tr.
  • Department of Molecular Biology and Genetics, Institute of Graduate Studies in Sciences, Istanbul University, Istanbul, Türkiye.
  • Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Balabanağa, Şehzadebaşı RoadVezneciler-Fatih, 34134, Istanbul, Türkiye.
  • Department of Molecular Biology and Genetics, Basic Medical Sciences, School of Medicine, Koç University, Istanbul, Türkiye.
  • Department of Biology, Institute of Graduate Studies in Sciences, Istanbul University, Istanbul, Türkiye.
  • Department of Biology, Faculty of Science, Istanbul University, Istanbul, Türkiye.

ORCID-Profile: Murat Pekmez, Şefika Beyza Mete, Yunus Aksüt, İrem Öğütcü, Fatma Nur Baştürk, Yusuf Can Gerçek, Aslıhan Şengelen

Förderung

  • Istanbul Üniversitesi
  • Istanbul University

Zitieren

APA

Pekmez, M., Mete, Ş. B., Aksüt, Y., Öğütcü, İ., Baştürk, F. N., Gerçek, Y. C., & Şengelen, A. (2025). Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis. Medical Oncology, 42(5). https://doi.org/10.1007/s12032-025-02697-2

Vancouver

Pekmez M, Mete ŞB, Aksüt Y, Öğütcü İ, Baştürk FN, Gerçek YC, et al. Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis. Medical Oncology. 2025;42(5). doi:10.1007/s12032-025-02697-2

BibTeX
@article{Pekmez2025,
  author = {Pekmez, Murat and Mete, Şefika Beyza and Aksüt, Yunus and Öğütcü, İrem and Baştürk, Fatma Nur and Gerçek, Yusuf Can and Şengelen, Aslıhan},
  title = {Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis},
  journal = {Medical Oncology},
  year = {2025},
  volume = {42},
  number = {5},
  doi = {10.1007/s12032-025-02697-2}
}
Kostenlos starten →